Sera Prognostics Inc (SERA)
10.44
-1.25
(-10.69%)
USD |
NASDAQ |
May 01, 16:00
10.45
+0.01
(+0.10%)
After-Hours: 20:00
Sera Prognostics Free Cash Flow (Quarterly): -6.781M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.781M |
| September 30, 2023 | -7.62M |
| June 30, 2023 | -7.995M |
| March 31, 2023 | -4.92M |
| December 31, 2022 | -7.431M |
| September 30, 2022 | -9.149M |
| June 30, 2022 | -9.257M |
| March 31, 2022 | -9.564M |
| Date | Value |
|---|---|
| December 31, 2021 | -9.901M |
| September 30, 2021 | -9.725M |
| June 30, 2021 | -6.323M |
| March 31, 2021 | -6.991M |
| December 31, 2020 | -4.229M |
| September 30, 2020 | -4.006M |
| June 30, 2020 | -4.159M |
| March 31, 2020 | -4.623M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-9.901M
Minimum
Dec 2021
-4.006M
Maximum
Sep 2020
-7.042M
Average
-7.211M
Median
Free Cash Flow (Quarterly) Benchmarks
| RadNet Inc | 37.94M |
| DermTech Inc | -12.54M |
| iSpecimen Inc | -0.6873M |
| 23andMe Holding Co | -14.07M |
| Progyny Inc | 36.98M |